Laboratoire de Parasitologie-Mycologie, Plateau de Microbiologie, Niveau +3, Batiment PC Bio, CHU Jean Minjoz, Bd Fleming, 25000 Besançon
Laurence Millon
Professor
PATHOGENES
lmillon@-Code to remove to avoid SPAM-chu-besancon.fr
+33 (0)3 70 63 23 53
Student :
Molecular biology, immunology, epidemiology, diagnostics,
Invasive fungal infections, resistance, parasitic infections, echinococcosis, allergies, hypersensitivity pneumonitis
Head of the Parasitology-Mycology Laboratory, Besançon University Hospital (since 2008)
Head of the National Echinococcosis Reference Centre (since 2012)
Coordinator of 9 national/international research projects over the last 10 years
Hospital work: diagnosis of fungal and parasitic infections, development of new techniques (biomarker for monitoring echinococcosis, molecular diagnosis of invasive fungal infections, development of recombinant antigens/serodiagnosis of hypersensitivity pneumonitis).
Research activity: molecular epidemiology, host-parasite interaction, antifungal resistance, microbiological environment and allergic respiratory pathologies
Current projects :
- HIS QPCR ECHINO: High Sensitive DNA qPCR for Echinococcosis Diagnosis – Call for projects Innovation CHU Besançon- 2023-2025
- BM-ASPICU: Non-invasive tools to better diagnose invasive aspergillosis infections in ICU patients with covid-19 and other non-immunosuppressive conditions – PFIZER Global Grant / CHU Besançon – 2022-2024
- EMBRASE : Environnement Microbiologique et Risque Allergique, cohorte d’enfants de 5 ans (cohorte ELFE) – Agence Nationale de la Recherche (APP ANR 2017) 2018-2022
- MODIMUCOR : Evaluation prospective d’un nouvel outil moléculaire pour le diagnostic précoce de la mucormycose – PHRC national (Ministère de la Santé) 2014-2022
Project submitted :
- GAP-AFR : Bridging the gap between environment and patient ; investigating the risk and transmission of antifungal resistance in Aspergillus fumigatus – proposition complete soumise en juin 2023 à l’appel d’offre JPIAMR-ACTION
- Joint Programming Initiative on Antimicrobial Resistance
PHRC AmbisaMucor: Optimized Liposomal Amphotericin B and Isavuconazole combination for Mucormycosis Treatment – Letter of intent submitted – October 2023
https://www.researchgate.net/profile/Laurence_Millon